Project Vitality: Pfizer Pursues Vaccine R&D Expansion

Pfizer is planning a $470-million expansion of its Vaccine Research and Development facilities in Pearl River, NY.

Related Keywords

Long Island City ,New York ,United States ,Rockland ,Times Square ,Philadelphia ,Pennsylvania ,New Jersey ,Rockland County ,Nanuet ,Cambridge ,Cambridgeshire ,United Kingdom ,California ,Palisades ,Pearl River ,American ,Steve Bjornson ,Profectus Biosciences ,Ernst Lederle ,Jamie Schwartz ,Nancyj Kelley ,Aurobindo Pharma ,Pfizer ,Groupb Streptococcus ,Metro North Railroad ,American Home Products ,Netflix ,Vaccine Research ,Industrial Realty Group ,Schwartz ,American Cyanamid ,Protein Sciences ,York Center ,New York City ,Breakthrough Therapy ,Priority Review ,Pfizer Vaccines ,Lederle Labs ,Los Angeles Based ,New York Center ,Hudson Valley ,Aurobindo Pharma United States ,Indian Based Aurobindo ,Good Manufacturing Practices ,River Laboratories ,Momentive Performance Materials ,Pearl River Studios ,Most Wanted ,New Black ,New York State Thruway ,Garden State ,Palisades Interstate ,New Jersey Transit ,Pascack Valley ,